{"id":535269,"date":"2021-09-07T19:43:55","date_gmt":"2021-09-07T23:43:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/"},"modified":"2021-09-07T19:43:55","modified_gmt":"2021-09-07T23:43:55","slug":"genocea-to-present-at-upcoming-scientific-and-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/","title":{"rendered":"Genocea to Present at Upcoming Scientific and Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CAMBRIDGE, Mass., Sept.  07, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=icJYXDauT_6z8aH6Ji-PG8onCEUKVweXSdRmMw3F68hJ38iVzK10ABh2Qk_kX0r9lu2QYWQx3rfHXYIA0XNMDZzM92X25-kS4TdDQpEp3yc=\" rel=\"nofollow noopener\" target=\"_blank\"><u>Genocea Biosciences, Inc.<\/u><\/a> (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following virtual conferences in September.<\/p>\n<p>\n        <strong>Scientific conferences:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%;vertical-align: top\">Event:<\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%;vertical-align: top\">Next Generation Cancer Vaccine Development Summit \u2013 <a href=\"https:\/\/hopin.com\/events\/next-generation-cancer-vaccine-development-summit\" rel=\"nofollow noopener\" target=\"_blank\"><u>Details<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Topic:<\/td>\n<td style=\"vertical-align: top\">Neoantigen selection to identify immunogenic tumor specific targets personalized to each patient\u2019s tumor and immune system<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Format:<\/td>\n<td style=\"vertical-align: top\">Post Conference Workshop<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Date:<\/td>\n<td style=\"vertical-align: top\">Thursday, September 9<sup>th<\/sup><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Time:<\/td>\n<td style=\"vertical-align: top\">1:00 p.m. ET<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>Investor conferences:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%;text-align: justify;vertical-align: middle;vertical-align: top\">Event:<\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%;text-align: justify;vertical-align: middle;vertical-align: top\">H.C. Wainwright 22nd Annual Global Investment Conference (virtual) \u2013 <a href=\"https:\/\/ir.genocea.com\/events-presentations\" rel=\"nofollow noopener\" target=\"_blank\"><u>Details<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Format:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Presentation<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Date:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Monday, September 13<sup>th<\/sup><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Time:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">7:00 a.m. ET<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:10%;width:10%;min-width:10%;vertical-align: top\">Event:<\/td>\n<td style=\"max-width:90%;width:90%;min-width:90%;vertical-align: top\">Baird Global Healthcare Conference 2021 (virtual) \u2013 <a href=\"https:\/\/www.bairdconferences.com\/conference2\/Index\/33\" rel=\"nofollow noopener\" target=\"_blank\"><u>Details<\/u><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Format:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Presentation<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Date:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Wednesday, September 15<sup>th<\/sup><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Time:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">11:25 a.m. ET<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About Genocea Biosciences, Inc.<\/strong><br \/>\n        <br \/>Genocea\u2019s mission is to identify the right tumor targets to develop life-changing immunotherapies for people suffering from cancer. Our proprietary ATLAS\u2122 platform can comprehensively profile each patient\u2019s T cell responses to potential targets, or antigens, on that patient\u2019s tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, Inhibigens\u2122, that drive pro-tumor immune responses. We are conducting a Phase 1\/2a clinical trial for GEN-011, our investigational adoptive T cell therapy comprising neoantigen-targeted peripheral cells. We continue to monitor patients in our phase 1\/2a clinical trial for GEN-009, our investigational neoantigen vaccine. In addition to our two clinical programs, we are conducting research in several areas where we believe ATLAS could be a key tool in optimizing antigen selection for therapies across a number of diseases. To learn more, please visit https:\/\/www.genocea.com.<\/p>\n<p>\n        <strong>Forward-Looking Statements<br \/><\/strong>This press release includes forward-looking statements related to GEN-011, GEN-009 and research updates within the meaning of the Private Securities Litigation Reform Act. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Genocea cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties that change over time. These factors include, but are not limited to, risks related to the potential failure of our active product candidates which are in an early stage of clinical development; our ability to obtain regulatory approval for our current and future product candidates; potential delays in enrolling patients in our clinical trials; our reliance on third parties to conduct technical development, non-clinical studies and clinical trials for our product candidates; our reliance on third parties to conduct some or all aspects of our product manufacturing; our ability to obtain or protect intellectual property rights related to our product candidates; the potential impacts of COVID-19 on our business and financial results; changes in law, regulations, or interpretations and enforcement of regulatory guidance; our need for additional financing and the risks listed under \u201cRisk Factors\u201d in our annual report on Form 10-K for the year ended December 31, 2020 and any subsequent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release and Genocea assumes no duty to update forward-looking statements, except as may be required by law.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Dan Ferry<br \/>617-430-7576<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9QHk0ZE27uijPmoOQYovJ1UHSqf1GRQ45Mbms0c0xXMY66c3bNORkcVvlyKLzK1AHi-Y8alkID7XXhAdLFXDmOprTcYETFNQ7Ckb-vSuOMb1a54jsH82PAVcltLUJlao\" rel=\"nofollow noopener\" target=\"_blank\"><u>daniel@lifesciadvisors.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Sarah O\u2019Connell<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4UKGlma7DeTAUNPL1HzuLtoIOZsIQz1ZBFYRt0li0q8THIGLkWN3OBZNE2QSWXcftVsaRvl-UH1iN49f6wEhJ8JJKyd_6HY3fe8Cx12GItpcLNJ3aSsWIQyDU8VSYXzH\" rel=\"nofollow noopener\" target=\"_blank\"><u>soconnell@vergescientific.com<\/u><\/a>\u00a0\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OTAzNDI5NTEtMmQwZS00YzhkLWE0NzAtMWZlNWI0M2IwODUxLTEwMTcxMTY=\/tiny\/Genocea-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following virtual conferences in September. Scientific conferences: Event: Next Generation Cancer Vaccine Development Summit \u2013 Details Topic: Neoantigen selection to identify immunogenic tumor specific targets personalized to each patient\u2019s tumor and immune system Format: Post Conference Workshop Date: Thursday, September 9th Time: 1:00 p.m. ET Investor conferences: Event: H.C. Wainwright 22nd Annual Global Investment Conference (virtual) \u2013 Details Format: Presentation Date: Monday, September 13th Time: 7:00 a.m. ET Event: Baird Global Healthcare Conference 2021 (virtual) \u2013 Details Format: Presentation Date: Wednesday, September 15th Time: 11:25 a.m. ET About Genocea Biosciences, Inc. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Genocea to Present at Upcoming Scientific and Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535269","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Genocea to Present at Upcoming Scientific and Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genocea to Present at Upcoming Scientific and Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following virtual conferences in September. Scientific conferences: Event: Next Generation Cancer Vaccine Development Summit \u2013 Details Topic: Neoantigen selection to identify immunogenic tumor specific targets personalized to each patient\u2019s tumor and immune system Format: Post Conference Workshop Date: Thursday, September 9th Time: 1:00 p.m. ET Investor conferences: Event: H.C. Wainwright 22nd Annual Global Investment Conference (virtual) \u2013 Details Format: Presentation Date: Monday, September 13th Time: 7:00 a.m. ET Event: Baird Global Healthcare Conference 2021 (virtual) \u2013 Details Format: Presentation Date: Wednesday, September 15th Time: 11:25 a.m. ET About Genocea Biosciences, Inc. &hellip; Continue reading &quot;Genocea to Present at Upcoming Scientific and Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T23:43:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Genocea to Present at Upcoming Scientific and Investor Conferences\",\"datePublished\":\"2021-09-07T23:43:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/\"},\"wordCount\":535,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/\",\"name\":\"Genocea to Present at Upcoming Scientific and Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=\",\"datePublished\":\"2021-09-07T23:43:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genocea to Present at Upcoming Scientific and Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genocea to Present at Upcoming Scientific and Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Genocea to Present at Upcoming Scientific and Investor Conferences - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following virtual conferences in September. Scientific conferences: Event: Next Generation Cancer Vaccine Development Summit \u2013 Details Topic: Neoantigen selection to identify immunogenic tumor specific targets personalized to each patient\u2019s tumor and immune system Format: Post Conference Workshop Date: Thursday, September 9th Time: 1:00 p.m. ET Investor conferences: Event: H.C. Wainwright 22nd Annual Global Investment Conference (virtual) \u2013 Details Format: Presentation Date: Monday, September 13th Time: 7:00 a.m. ET Event: Baird Global Healthcare Conference 2021 (virtual) \u2013 Details Format: Presentation Date: Wednesday, September 15th Time: 11:25 a.m. ET About Genocea Biosciences, Inc. &hellip; Continue reading \"Genocea to Present at Upcoming Scientific and Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T23:43:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Genocea to Present at Upcoming Scientific and Investor Conferences","datePublished":"2021-09-07T23:43:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/"},"wordCount":535,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/","name":"Genocea to Present at Upcoming Scientific and Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=","datePublished":"2021-09-07T23:43:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMTc5MSM0MzkzNzIwIzIwMDU1NDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genocea-to-present-at-upcoming-scientific-and-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Genocea to Present at Upcoming Scientific and Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535269"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535269\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}